Infectious diseases Archives - Page 12 of 33

Clinical Articles

New COVID variants prompt booster drive

New COVID variants BQ.1 and XBB now account for 10% of Victoria’s case numbers, and are expected to overtake BA.5 as the dominant Omicron variant in Australia.

Podcasts

Get up to speed on the new COVID wave

The new COVID wave comprising of BQ1, XBB and other variants, and what our frontline response should look like, whether a fifth booster is worth having, children's vaccination developments and an update on the antivirals

Clinical Articles

“It’s not over yet” stresses expert

Infections and deaths from COVID-19 are still occurring and the pandemic is not over

Podcasts

Intersection between COVID and tuberculosis

How resources are being diverted to COVID-19, and how they have been affecting Tuberculosis resources, knowing when to suspect and diagnose active Tuberculosis and how to manage the patient

Clinical Articles

Cruise ships are back and carrying COVID. No, it’s not 2020. But here’s what needs to happen next

Cruise ships carrying passengers with COVID are back in the news...

Clinical Articles

From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more worrying than others)

The Omicron variant of concern has splintered into multiple subvariants.

Expert/s: Healthed

Podcasts

COVID update – Bivalent jab, new variants and herd immunity

The bivalent vaccines, the new variant alert for Ba.2.75 and Ba.4.6, and herd immunity predictions and implications

Clinical Articles

If you think scrapping COVID isolation periods will get us back to work and past the pandemic, think again

COVID is an exceptional disease and was at its deadliest this year, causing more deaths in Australia between June and August 2022 than at any other time.

Videos

Understanding the advantages of cell-based influenza vaccines

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains Australia’s first and only cell-based influenza vaccine, as well as the differences between influenza vaccines and why this is important to understand in order to better inform patients of the choices available (5 mins).

Podcasts

Lagevrio questions, mRNA jab misunderstandings and nasal vaccines coming

Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time. Additionally COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed

Podcasts

Bivalent vaccines and other recent developments

The elimination of isolation periods and mask mandates, and an update on the vaccination landscape, including recently approved jabs, the bivalent vaccine, and vaccination for children

Clinical Articles

Vaccines build on herd immunity

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

Infectious diseases

New COVID variants prompt booster drive

New COVID variants BQ.1 and XBB now account for 10% of Victoria’s case numbers, and are expected to overtake BA.5 as the dominant Omicron variant in Australia.

Get up to speed on the new COVID wave

The new COVID wave comprising of BQ1, XBB and other variants, and what our frontline response should look like, whether a fifth booster is worth having, children's vaccination developments and an update on the antivirals

“It’s not over yet” stresses expert

Infections and deaths from COVID-19 are still occurring and the pandemic is not over

Intersection between COVID and tuberculosis

How resources are being diverted to COVID-19, and how they have been affecting Tuberculosis resources, knowing when to suspect and diagnose active Tuberculosis and how to manage the patient

Cruise ships are back and carrying COVID. No, it’s not 2020. But here’s what needs to happen next

Cruise ships carrying passengers with COVID are back in the news...

From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more worrying than others)

The Omicron variant of concern has splintered into multiple subvariants.

COVID update – Bivalent jab, new variants and herd immunity

The bivalent vaccines, the new variant alert for Ba.2.75 and Ba.4.6, and herd immunity predictions and implications

If you think scrapping COVID isolation periods will get us back to work and past the pandemic, think again

COVID is an exceptional disease and was at its deadliest this year, causing more deaths in Australia between June and August 2022 than at any other time.

Understanding the advantages of cell-based influenza vaccines

Lagevrio questions, mRNA jab misunderstandings and nasal vaccines coming

Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time. Additionally COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed

Bivalent vaccines and other recent developments

The elimination of isolation periods and mask mandates, and an update on the vaccination landscape, including recently approved jabs, the bivalent vaccine, and vaccination for children

Vaccines build on herd immunity

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

Get the app

Site

Company

Connect

Legal

Healthed

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.

Infectious diseases

New COVID variants BQ.1 and XBB now account for 10% of Victoria’s case numbers, and are expected to overtake BA.5 as the dominant Omicron variant in Australia.

The new COVID wave comprising of BQ1, XBB and other variants, and what our frontline response should look like, whether a fifth booster is worth having, children's vaccination developments and an update on the antivirals

Infections and deaths from COVID-19 are still occurring and the pandemic is not over

How resources are being diverted to COVID-19, and how they have been affecting Tuberculosis resources, knowing when to suspect and diagnose active Tuberculosis and how to manage the patient

Cruise ships carrying passengers with COVID are back in the news...

The Omicron variant of concern has splintered into multiple subvariants.

The bivalent vaccines, the new variant alert for Ba.2.75 and Ba.4.6, and herd immunity predictions and implications

COVID is an exceptional disease and was at its deadliest this year, causing more deaths in Australia between June and August 2022 than at any other time.

Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time. Additionally COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed

The elimination of isolation periods and mask mandates, and an update on the vaccination landscape, including recently approved jabs, the bivalent vaccine, and vaccination for children

Almost three years into the pandemic, the widespread uptake of vaccines in Australia, together with the large rate of infection from the Omicron variant has created very good population immunity, according to Professor Kristine Macartney from the National Centre for Immunisation Research.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Extra Details

Healthed

Upcoming Healthed Webcast

Rosacea – Smarter diagnosis & state-of-the-art care

Tuesday 14th April, 7pm - 9pm AEST

Speaker

Dr Belinda Welsh

Dermatologist; Senior Vice President, Australasian Society of Cosmetic Dermatologists

Join Dr Belinda Welsh, who will also present a practical framework for the effective management of rosacea, a condition that can be controlled by not cured.